{
    "Trade/Device Name(s)": [
        "MicroScan Synergies plus Gram-Positive MIC/Combo Panels with oxacillin"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K071076",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LRG",
        "LTT",
        "LWY"
    ],
    "Summary Letter Date": "April 13, 2007",
    "Summary Letter Received Date": "April 16, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.1645"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Oxacillin"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of Gram-positive enterococci and staphylococci"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan Rapid Fluorogenic Identification",
        "MicroScan WalkAway SI",
        "MicroScan Instrumentation"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution susceptibility testing",
        "Dehydrated panel rehydration",
        "Turbidity inoculum preparation"
    ],
    "Methodologies": [
        "Quantitative and qualitative antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan Synergies plus Gram-Positive MIC/Combo Panels with oxacillin for antimicrobial susceptibility testing of Gram-positive staphylococci and enterococci.",
    "Indications for Use Summary": "Determines quantitative and/or qualitative antimicrobial agent susceptibility of colonies of rapidly growing aerobic and facultative anaerobic Gram-positive enterococci and staphylococci using oxacillin in various MIC/breakpoint sequences.",
    "fda_folder": "Microbiology"
}